top of page
Search
Psilocybin Research: A New Era in Alcohol Addiction Treatment?
Treating alcohol use disorder (AUD) is one of the most challenging tasks in modern medicine, with high relapse rates and varied patient...
Dec 13, 2024
EU Grants €6.5M for Groundbreaking Psilocybin Study in Palliative Care
A Milestone for Psychedelic Research in Europe Earlier this year, in a landmark decision, the European Union has awarded €6.5 million to...
Oct 8, 2024
Exploring the Untapped Potential of African Psychedelic Mushrooms
In the world of psychoactive mushrooms, the genus Psilocybe stands out for its storied history and widespread intrigue. Home to around...
Jul 18, 2024
Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence Driven In-Home Mycelium Production
Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce the addition of significant...
Jul 17, 2024
Optimi Health Corp. Granted License to Export Psilocybin and MDMA Drugs to Australia
Canada has made a significant move in the field of medical psychedelic drugs by granting a drug establishment license to Optimi Health...
Jun 10, 2024
bottom of page